Division of Pharmaceutical Technology and Biopharmacy
Division of Pharmaceutical Technology and Biopharmacy
Prof. Dr. Dagmar Fischer
The Fischer group is focussed on the development of natural and synthetic micro- and nanocarriers for drug delivery in the field of infection, inflammation and inflammation-related diseases as well as aging. A major focus is related to biopharmaceutical test systems according to the 3R principle to investigate the life cycle of drug delivery systems and the influence of the physiological environment. Furthermore, nanosafety and safe-by-design concepts as well as quality assurance concepts are provided
News
Fabian Döll presents at the Research Day efs-NeW
Jan Westhoff at the National Research Council Canada
Meet the Fischer Group at CRS 2024 Annual Meeting and Expo in Bologna!
Woman in Science at FAU
27.06.2024 DPhG – Vortrag: “Neue Modalitäten in der Arzneistoffentwicklung”
Congratulations to Ula Savsek!
06.06.2024 DPhG – Vortrag: “Stammzell – technologien in der Arzneistoffentwicklung und Regenerativen Medizin”
CRC PolyTarget PhD student meeting at 24 May 2024 in Erlangen
Pharmaziestudierende der FAU: Exkursion zu Roche
25. April 2024 DPhG hybrid: Best of Neue Arzneistoffe 2023 – Wirkmechanismen und therapeutische Bedeutung für die Praxis verstehen!